| Financial Year |
March 31 2023 |
| Monetary Funds |
3,247,127,868.05 |
| Held-for-trading Financial Assets |
99,048,707.84 |
| Notes Receivable |
400,000.00 |
| Accounts Receivable |
239,212,689.97 |
| Advances to Suppliers |
23,818,115.12 |
| Other Receivables |
376,990,952.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
22,928,795,869.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,192,581,874.37 |
| Total Current Assets |
28,107,976,077.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,147,429,762.58 |
| Investment Properties |
3,876,825,084.70 |
| Fixed Assetes |
641,651,954.03 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,576,436.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,887,427.01 |
| Deferred Income Tax Assets |
1,104,443,792.55 |
| Other Non-Current Assets |
52,746,505.54 |
| Sub-Total of Non-Current Assets |
6,891,800,987.93 |
| Total Assets |
34,999,777,065.57 |
| Short-Term Loans |
118,921,605.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
224,867,980.25 |
| Accounts Payable |
1,787,649,185.26 |
| Accounts Received In Advance |
10,587,277.76 |
| Employee Compensation Payable |
4,192,078.61 |
| Taxes Payable |
1,896,116,069.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,000,172,757.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,093,240,125.10 |
| Other Current Liabilities |
975,904,065.91 |
| Sub-Total of Current Liabilities |
19,202,324,919.41 |
| Long-term Loans |
2,966,156,496.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,653,107.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,985,455,813.55 |
| Total Liabilities |
22,187,780,732.96 |
| Paid-In Capital(Or Share Stock) |
2,475,325,057.00 |
| Capital Surplus |
5,836,485,917.34 |
| Surplus Reserve |
527,323,587.62 |
| LESS:Treasury Stock |
530,130,843.75 |
| Undistributed Profits |
4,203,185,173.05 |
| Minority Stockholder's Interest |
393,528,713.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,418,467,619.33 |
| Owner's Equity（Stockholder's Equity） |
12,811,996,332.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
34,999,777,065.57 |
